Firstly, we observed downregulation of anti-inflammatory genes such as SMAD2 and SOCS1 that downregulates inflammatory cytokine secretion by inhibiting JAK/STAT pathway in patients with RA, but not during early disease stages. The gene discussed is SOAT1; the disease is rheumatoid arthritis.